Strategic Environmental Assessment in Biotechnology

Introduction

Strategic Environmental Assessment (SEA) is a process used to evaluate the likely environmental consequences of policies, plans and programmes before they are adopted. In biotechnology, SEA examines the broader environmental effects of decisions involving genetically modified organisms (GMOs), synthetic biology, biofuel production, industrial biotechnology, large-scale biomanufacturing and biotechnology research infrastructure.

Unlike an Environmental Impact Assessment (EIA), which generally examines the effects of a particular project, SEA considers alternatives, cumulative impacts and long-term environmental risks at an earlier planning stage. Its purpose is to ensure that biotechnology development is consistent with environmental protection, public health and sustainable development.

1. Legal Framework in India

India does not have a separate, comprehensive statute that makes SEA compulsory for every biotechnology policy or programme. Instead, environmental assessment is carried out through several laws and regulatory mechanisms:

Environment (Protection) Act, 1986: Sections 3 and 6 empower the Central Government to take measures for environmental protection and frame rules.

Environment (Protection) Rules, 1986: Rule 5 enables restrictions on the location and operation of industries and processes.

Environment (Protection) Rules, 1989: These regulate the manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms or cells.

EIA Notification, 2006: Requires prior environmental clearance for specified categories of projects. It is a project-level mechanism, not a general SEA requirement for all biotechnology policies.

Constitution of India: Articles 21, 48A and 51A(g) support the protection of the environment and ecological balance.

The 1989 Rules establish a regulatory structure involving bodies such as the Genetic Engineering Appraisal Committee (GEAC), Review Committee on Genetic Manipulation (RCGM) and Institutional Biosafety Committees (IBSCs).

2. Importance and Scope of SEA in Biotechnology

SEA is particularly relevant where biotechnology decisions may have wide or long-term environmental consequences. It should examine:

Biodiversity: Whether genetically modified organisms may affect native species, traditional crops and ecological diversity.

Gene transfer: The possibility of modified genes spreading to non-modified plants or related species.

Soil and water: The potential effects of biotechnology activities on soil organisms, groundwater and aquatic ecosystems.

Cumulative impacts: The combined environmental effects of several biotechnology projects operating in one region.

Alternative technologies: Whether safer or less environmentally damaging methods can achieve the same objectives.

Public participation: Whether farmers, local communities, scientists and environmental organisations receive meaningful opportunities to contribute.

SEA should also provide for long-term monitoring, transparent scientific data and corrective measures when unexpected environmental effects arise.

3. Important Case Laws

(a) Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and the polluter-pays principle as essential elements of Indian environmental law. It held that environmental authorities must anticipate and prevent environmental damage even where scientific certainty is incomplete. This principle supports early strategic assessment of biotechnology risks.

LegalRes+1

(b) A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718; (2000) 2 SCC 718

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making. It recognised that technical uncertainty requires careful assessment and expert assistance. This is relevant to biotechnology policies involving complex genetic and ecological risks.

Indian Kanoon+1

(c) Gene Campaign v. Union of India, 2024 INSC 545

This important case concerned regulatory approval for the environmental release of genetically modified mustard (DMH-11). The two judges delivered separate opinions and differed on the validity of the approval. Justice B.V. Nagarathna emphasised the need for detailed risk assessment, biodiversity protection and consideration of long-term environmental consequences. Justice Sanjay Karol took a different view of the regulatory decision. The judgment is particularly significant for transparency, scientific evaluation and precaution in biotechnology governance.

Sci API+1

(d) Alembic Pharmaceuticals Ltd. v. Rohit Prajapati (2020) 17 SCC 157

The Supreme Court disapproved the routine grant of ex-post-facto environmental clearance. The decision reinforces the importance of assessing environmental consequences before industrial activity begins, a principle relevant to biotechnology manufacturing facilities.

4. Challenges and Conclusion

The major challenges include scientific uncertainty, insufficient long-term studies, limited public participation, regulatory coordination and the difficulty of assessing cumulative ecological effects. A further challenge is that India's existing framework does not establish a universal, independent SEA procedure for biotechnology policies and programmes.

Strategic Environmental Assessment can therefore strengthen biotechnology governance by integrating environmental protection into policy-making from the beginning. It promotes scientific accountability, biodiversity conservation, sustainable development and intergenerational equity. Although Indian law primarily relies on project-level EIA and specialised biosafety regulation, the principles recognised by the Supreme Court provide a strong legal foundation for broader strategic assessment of biotechnology decisions.